Budding Forensic Expert · Forensic Genetics Review

The New DNA Revolution: What Changed in Forensic Genetics Between 2023–2025?

From matching a profile to reconstructing an activity: three years that redefined what a biological trace can be asked to say — and what the profession decided it still cannot.

Based on the INTERPOL Review of Forensic Biology and DNA, 2023–2025, and the primary peer-reviewed literature

Fig. 0 — The DNA double helix as a metaphor for the period: the same underlying molecule, read for far more than identity alone.

A DNA profile used to answer one question: whose is this? Between 2023 and 2025, forensic genetics spent three years quietly redefining the question itself — asking not just who left biological material behind, but how it got there, what it reveals about the person who left it, and how confidently any of that can be stated in court. This is a critical look at what genuinely changed, what merely got louder, and what still hasn't moved at all.

The DNA Profile Is No Longer the Whole Story

For three decades, the basic unit of forensic DNA analysis was the short tandem repeat (STR) profile and the question it was built to answer: does this profile match that person? The period 2023–2025 did not overturn that foundation. What it did was surround it — with statistical software that replaces binary matching with graded evidential weight, with methods that ask how a stain got somewhere rather than only whose it is, with sequencing technology that reads more of the genome than any STR panel ever could, and with a hard, overdue conversation about what all of this evidence can and cannot responsibly say.

The most authoritative single account of this period comes from the INTERPOL Review of Forensic Biology and DNA, 2023–2025, prepared by forensic scientist John M. Butler for the 21st INTERPOL International Forensic Science Managers Symposium and published in Forensic Science International: Synergy in June 2026 as a retrospective survey of the triennium.^[1] Butler's team combed almost 2,000 publications across more than 300 journals — 24 books and major reports, 20 special journal issues, 292 conference papers from two International Society for Forensic Genetics (ISFG) meetings, and 70 guidance documents from 17 standards bodies — and sorted them into fifteen topic areas.^[1] That review is the roadmap for this article, but not its only source: every major claim below has been checked against the underlying peer-reviewed literature, government guidance, and — where evidence exists — the Indian forensic policy record.

One methodological note from the review itself is worth flagging up front, because it says something about the pace of the field: Butler's team used AI-assisted summarisation tools to help manage the sheer volume of literature — nearly 1,900 publications in three years, on forensic DNA and biology alone.^[1] That is itself a small data point about how fast this discipline is now producing evidence.

1. What Was Forensic DNA Analysis Before 2023?

Walk into a well-run DNA laboratory in 2022 and the core workflow would have been recognisable to a scientist from 2010: extract DNA, amplify a panel of autosomal STR loci by capillary electrophoresis, compare the resulting profile to a reference sample, and report a match probability. Laboratories increasingly used probabilistic genotyping software to interpret mixtures rather than manual binary rules, and a smaller number were beginning to use massively parallel sequencing (MPS) for casework beyond routine STR typing. Investigative genetic genealogy had already solved the Golden State Killer case in 2018 and hundreds of cases since, operating under a U.S. Department of Justice interim policy issued in 2019.^[2] Activity-level DNA interpretation — evaluating how DNA got somewhere rather than simply whose it is — was established in parts of Europe, particularly the Netherlands and the UK, but remained rare in American casework and largely absent from routine Indian forensic practice. DNA phenotyping tools such as HIrisPlex-S could predict eye, hair, and skin colour categories from degraded or low-template samples with useful accuracy, but they remained supplementary intelligence tools, not identification methods.^[3]

In short: the building blocks of the "new DNA revolution" already existed before 2023. What the 2023–2025 period supplies is not invention so much as validation, standardisation, scale, and — in several areas — a necessary correction of overreach.

2. Why 2023–2025 Became an Important Period

Three forces converged. First, probabilistic genotyping software had matured enough by the early 2020s that laboratories worldwide needed harmonised validation guidance — hence a wave of inter-laboratory comparison studies and regulator guidance issued precisely in this window.^[4][5] Second, activity-level DNA interpretation — long a research topic — reached the point where a major US standards body felt compelled to issue a formal position statement on it, a sign the debate had moved from academic to operational.^[6] Third, sequencing costs kept falling, pushing microhaplotypes, forensic DNA phenotyping, and epigenetic methylation analysis out of proof-of-concept papers and into developmental-validation studies with real accuracy numbers attached.^[7][8]

Fig. 2 — The three pressures that made 2023–2025 a pivotal window for forensic genetics.

None of this happened in a vacuum. The period also included concrete, high-stakes human identification events — most visibly the August 2023 Lahaina wildfire on Maui, where Rapid DNA technology was used to identify victims within hours rather than the months such identifications historically required — that tested these methods under real pressure.^[9][10]

3. Probabilistic Genotyping: From Matching to Statistical Interpretation

The Problem

Complex DNA mixtures — three, four, or more contributors, some at trace levels — routinely defeat simple "is this allele present or absent" interpretation. Stochastic effects at low template levels (allele drop-out, drop-in, elevated stutter) make manual interpretation either impossible or dangerously subjective.

What Changed

Probabilistic genotyping software (PGS) — continuous statistical models such as STRmix, TrueAllele, and EuroForMix — was already in wide use before 2023. What changed during this period was the evidence base around how reliably different laboratories using different software and instruments arrive at the same answer. A 2024 inter-laboratory comparison examined probabilistic genotyping parameters and performance across laboratories processing the same DNA mixtures and found meaningful variability in likelihood ratios depending on laboratory-specific parameter choices — a finding with direct implications for how courts should weigh PGS output.^[4] A companion 2024 study compared likelihood ratios for two-person mixtures generated by different assays and instruments, again for the purpose of giving courts and the public a basis for judging the reliability of this evidence across laboratories.^[11] On the standards side, the UK Forensic Science Regulator issued an updated (Issue 2, July 2024) guidance document specifically on software validation for DNA mixture interpretation, and STRmix's own developmental validation for sequence (MPS-based) data was published in this window, extending probabilistic genotyping beyond capillary-electrophoresis STR data into the sequencing era.^[5][12]

How It Works

Continuous probabilistic genotyping software models the DNA typing process itself — peak heights, stutter, drop-out probability, and the number of contributors — to calculate the likelihood of observing the evidence profile under two or more competing propositions (for example, "the person of interest is a contributor" versus "the person of interest is not a contributor, but three unknown people are"). The output is a likelihood ratio (LR): a number expressing how much more probable the evidence is under one proposition than the other, not a statement of guilt.

Evidence, Status, and Limitations

PGS for mixture interpretation is established in the sense that it is now the norm in well-resourced laboratories, has ANSI/ASB and SWGDAM validation standards behind it, and has survived numerous admissibility challenges.^[5] But "established" is not "settled": the inter-laboratory variability findings above show that different validated implementations of the same underlying statistical approach can still produce different likelihood ratios for the identical evidence sample — a limitation that transparency and standardisation efforts are actively trying to close, not one that has disappeared.^[4]

Forensic Reality CheckA likelihood ratio measures the strength of evidence under two competing explanations. It is not a probability that the person is guilty, and treating it as one is a well-documented courtroom error known as the prosecutor's fallacy.

4. The Source–Activity Revolution

If one shift best captures "what changed" between 2023 and 2025, it is the normalisation — and simultaneous, necessary tempering — of activity-level DNA interpretation.

The Problem

Finding a person's DNA profile on an object answers a source-level question: whose is this? It does not, by itself, answer an activity-level question: how did it get there, and when? A defendant's DNA on a knife handle might come from having stabbed someone — or from having handled the knife in an unrelated kitchen a week earlier and having it secondarily transferred by someone else. As forensic laboratories got better at detecting ever-smaller amounts of trace DNA, courts increasingly asked "how" and "when" questions that source-level identity evidence alone cannot answer.

What Changed

The scientific literature on DNA transfer, persistence, prevalence, and recovery (TPPR) — the data needed to actually answer activity-level questions — expanded substantially in this period. A comprehensive 2025 review in Forensic Sciences synthesised the evidence on how DNA transfers, persists, and is recovered from different areas of the human body following different types of contact, an evidence base directly usable in casework activity-level assessments.^[13] A multi-laboratory project (the "ReAct" project) analysed data from 23 different laboratories to characterise DNA recovery under two sets of activity-level propositions — exactly the kind of cross-laboratory data pooling that activity-level evaluation has long needed.^[14] Dutch research published in 2024 examined household-environment TPPR scenarios directly relevant to disputes over how DNA came to be deposited rather than whether it is present at all, and separate 2024 research surveyed court-attending forensic scientists, finding that more than 60 percent of the questions they now face in court concern transfer, persistence, prevalence, and recovery rather than simple source identity.^[15][16]

The most important development, however, is a note of caution rather than celebration. In December 2025, the U.S. Scientific Working Group on DNA Analysis Methods (SWGDAM) — representing federal, state, and local forensic DNA laboratories — issued a formal position statement concluding that, in its present form, formal activity-level reporting is not suitable for use in U.S. forensic laboratories, even as it acknowledged that courts increasingly ask exactly these questions of testifying analysts.^[6] This is a genuinely important 2023–2025 development precisely because it complicates the "revolution" narrative: the underlying science of DNA transfer has matured considerably, but the leading American standards body concluded the profession is not yet ready to formalise it into standard reporting practice.

Current Status

Activity-level interpretation is established practice in the Netherlands and parts of the UK, where dedicated expert competency registration exists for it, but remains at an emerging, contested stage in the United States, and is largely research-stage or absent in Indian forensic casework, where TPPR data specific to Indian environmental and climatic conditions is scarce.

Forensic Reality CheckFinding someone's DNA and explaining how it arrived at the scene are different scientific questions, requiring different data, different propositions, and — the profession increasingly agrees — considerable caution before they are treated as equally settled.

5. Rapid DNA: From Laboratory to Near-Real-Time Analysis

The Problem

Conventional DNA analysis, even when expedited, takes hours to days of laboratory processing. For booking-station identification of arrestees, or for disaster victim identification under time pressure, that lag has real costs.

What Changed

Rapid DNA — automated, sample-to-profile instruments producing a result in roughly 90 minutes to two hours — moved further into operational use for one specific application: booking-station identification of qualifying arrestees. The FBI issued its first Rapid DNA "Authorization to Operate" for booking-station use to Louisiana in April 2022, followed by Florida in December 2022 and the FBI's own national systems in May 2023, placing the real operational rollout squarely inside this review period.^[17] In July 2025, the FBI updated its Quality Assurance Standards for Forensic DNA Testing Laboratories specifically to permit — for the first time — the processing of crime-scene evidence samples (not just arrestee reference swabs) using Rapid DNA instruments for subsequent CODIS upload.^[18]

Current Status and Limitations

This is a case where the honest answer is "meaningfully more mature, but still narrowly scoped." As of the July 2025 policy update, the FBI still had not approved any Rapid DNA cartridges for evidence processing, meaning the crime-scene-sample pathway remained procedurally open but technically unrealised at the close of the review period; official guidance continued to specify that only high-quality, single-source evidence samples should even be considered once cartridges are approved, and that sufficient sample must always be preserved for conventional laboratory confirmation.^[19] Booking-station Rapid DNA, by contrast, is genuinely operational — though still concentrated in a handful of U.S. states and dependent on IT infrastructure that not every jurisdiction has (Alaska's forensic laboratory, for instance, noted in 2025 that the state's networks could not yet support the real-time connectivity Rapid DNA booking requires).^[20] Complex forensic casework — mixtures, degraded remains, low-template samples — remains firmly outside Rapid DNA's current scope and continues to require conventional laboratory analysis.

Disaster victim identification is where Rapid DNA's operational maturity was tested most visibly in this period. Following the August 2023 Lahaina wildfire on Maui — the deadliest U.S. wildfire in more than a century — investigators used ANDE Rapid DNA instruments to identify victims within hours in some cases, a marked acceleration compared with the months typically required after comparable disasters such as the 2018 Camp Fire in Paradise, California.^[9][10] The identification effort still depended on the availability of family reference samples and on painstaking matching against degraded remains — a reminder that faster instruments do not eliminate the human and logistical bottlenecks of mass-fatality response.

6. MPS/NGS: Reading More Than STR Alleles

What Changed

Massively parallel sequencing (MPS, also called next-generation sequencing or NGS) was not new in 2023, but this period saw its infrastructure mature: the ISFG DNA Commission published formal recommendations on STR sequence nomenclature in 2024, addressing a basic standardisation problem — different laboratories describing sequence-level STR variation in incompatible ways — that had held back routine adoption.^[21] Developmental validation of probabilistic genotyping software specifically for MPS-derived sequence data (rather than capillary-electrophoresis length data) was completed and published, closing a key gap between sequencing and statistical interpretation.^[12] Implementation research also expanded beyond the traditionally MPS-heavy US and European laboratories: a 2025 University of Cape Town study documented, in detail, the practical challenges and workflow adaptations needed to bring MPS-based human identification into a resource-constrained South African forensic setting — directly relevant to India's own infrastructure questions.^[22]

Traditional STR Profiling vs. Sequence-Based Forensic Genetics

Capillary electrophoresis measures only the length of an STR repeat region. MPS reads the actual sequence, revealing internal variation invisible to length-based typing — two alleles of identical length can have different internal sequences, effectively adding new discriminating information without adding new genetic markers. MPS also allows STRs, SNPs, mitochondrial DNA, and Y-chromosome markers to be sequenced together in a single assay, and performs comparatively well on degraded, low-template samples.

Current Status

MPS is emerging to limited operational use globally — well-established in a subset of advanced laboratories, but its cost, bioinformatics training requirements, and database-compatibility challenges (national DNA databases like CODIS remain built around length-based STR data) mean it has not replaced capillary electrophoresis as the default forensic workflow anywhere.

7. Microhaplotypes and the Expansion of Genetic Information

The Problem

STR mixture deconvolution is undermined by PCR stutter and amplification-length artefacts, especially for minor contributors. SNPs are stable and abundant but individually carry little discriminating power and cannot resolve phase (which alleles sit together on the same chromosome).

What Changed

Microhaplotypes — clusters of two or more closely linked SNPs within a short DNA segment, sequenced together so their combined haplotype can be read directly — moved from a promising concept into funded, developmental-validation-stage panels during this period. A U.S. National Institute of Justice-funded project explicitly titled its multi-year microhaplotype panel-optimisation research "2023–2025," reporting combined match probabilities as discriminating as 10⁻⁵² to 10⁻⁶³, sensitivity down to 50 picograms of input DNA, and demonstrated biogeographic ancestry inference alongside mixture deconvolution.^[7] Separately, a 2024 Chinese study published in BMC Genomics developed and validated a new 33-locus microhaplotype panel, demonstrating its value for both kinship analysis and mixture deconvolution in a Han Chinese reference population, with cumulative power of discrimination exceeding 1 in 10⁴³.^[23]

Current Status and Limitations

Microhaplotypes are at a validation stage, not yet routine casework, and require population-specific allele-frequency databases before they can be deployed responsibly in any given country — a database that does not yet exist for Indian populations. They are best understood as a complement to STR typing for difficult mixtures and ancestry inference, not a replacement for the STR systems that national databases are built around.

8. DNA Phenotyping: Predicting Appearance From Biology

What Changed

Forensic DNA phenotyping (FDP) tools for eye, hair, and skin colour prediction (HIrisPlex-S and related systems) were already validated before 2023 and did not undergo a dramatic technical leap in this period. What changed was largely institutional and ethical: a September 2023 conference at the University of Luxembourg, convened under the EU-funded CRIMTYP project, brought together forensic geneticists, legal scholars, and ethicists specifically to examine the "technolegal mismatch" between what FDP can deliver and how legal systems are prepared to govern and constrain its use — a sign that the scientific community itself was pushing back against overstated claims about the technology.^[24] Research incrementally broadened the traits under investigation (age, more granular ancestry components) and continued refining accuracy for existing pigmentation traits, but no 2023–2025 development changed the fundamental, probabilistic nature of what FDP can offer.

Forensic Reality CheckDNA phenotyping is probabilistic prediction, not photographic identification. It can suggest that a trace donor probably has brown eyes and dark hair with a given confidence level; it cannot generate a face.

Current Status

FDP for pigmentation traits is at limited operational use as an investigative-lead tool in parts of Europe and the U.S.; broader appearance prediction (face shape, precise ancestry) remains research-stage. It is not used in routine Indian forensic casework, and no evidence surfaced of Indian regulatory frameworks specifically addressing it.

9. DNA Methylation and Epigenetic Forensics

The Problem

Conventional forensic biology cannot estimate the chronological age of a DNA donor or reliably identify which body fluid a stain came from once visual and immunological tests are inconclusive or the sample is too degraded for them.

What Changed

DNA methylation-based age estimation ("epigenetic clocks") and body-fluid identification continued to mature from a promising research technique into models with published, comparable accuracy figures. A 2023 systematic review in the Journal of Forensic Science and Medicine catalogued the sample types, conversion methods, and modelling approaches used across the growing epigenetic-clock literature.^[8] The more significant technical step came from sequencing-platform innovation: research on using Oxford Nanopore's PromethION platform for methylation analysis — enabling real-time, direct detection of methylation status without the bisulfite-conversion step that MPS-based methylation assays require — demonstrated a single-assay workflow combining epigenetic age estimation and body-fluid identification (blood and saliva) from low-input DNA samples, while also candidly reporting current limitations: at low sequencing read depth, methylation status was inaccurately forced to extreme values, and age predictions skewed older than true age until a correction model was applied.^[25]

Current Status

DNA methylation age estimation is best classified as validation stage, moving toward limited operational use for missing-persons and disaster-victim-identification casework where an age estimate meaningfully narrows a candidate pool. It is not yet a routine, courtroom-ready technique, and nanopore-based single-assay approaches remain firmly research-stage.

10. Investigative Genetic Genealogy

What Changed

Investigative genetic genealogy (IGG) — using distant genetic relationships found through consumer genealogy databases to build family trees toward an unknown suspect or unidentified remains — expanded steadily in case volume through this period without a single defining technical breakthrough. The available longitudinal case-tracking data (an academic dataset spanning cases resolved through IGG up to December 2024) documents this continued growth in adoption.^[26] The more consequential developments were methodological and ethical. A 2024 study in the Journal of Forensic Sciences formally analysed the privacy–performance trade-off of "reference testing" — the practice of law enforcement requesting a DNA sample from a living person identified through a partially built family tree, someone who never opted into forensic genealogical searching at all — quantifying just how much of an investigation's success depends on this ethically contested step.^[27] A separate 2024 paper in Biotechniques by a group of leading forensic geneticists proposed frameworks for prioritising privacy and presenting only statistically supportable hypotheses in IGG casework, an attempt to formalise standards for a field that had grown largely through case-by-case practice rather than codified methodology.^[28] A 2026 bibliometric review of the academic IGG literature — itself reviewing the 2023–2025 growth spurt — found research output continuing to accelerate after the field's 2018 inflection point, concentrated in the U.S., U.K., China, Sweden, and Australia, while flagging persistent gaps: limited multi-site validation, proprietary matching algorithms that resist independent audit, and ancestry-skewed database coverage that raises equity concerns for populations underrepresented in consumer genealogy databases — including, by clear implication, most Indian population groups.^[29]

Current Status

IGG is operational in the United States, increasingly formalised through dedicated FBI programme structures and refresher training, but remains constrained by database composition, cost, and case-eligibility rules that generally limit it to unsolved violent crime and unidentified-remains cases.^[30] It has no established operational presence in Indian law enforcement.

11. Solving the Problem of Degraded and Difficult DNA

Advances in MPS-based sequencing, microhaplotypes, and methylation-based age estimation converge most usefully on one humanitarian application: identifying people from severely compromised biological material — skeletal remains, fire-damaged tissue, decomposed bodies. The Maui wildfire response illustrates both the promise and the limits: Rapid DNA delivered some identifications within hours, but the overall identification effort for the more than 100 victims still depended on months of painstaking work, family reference-sample collection, and — for the most degraded remains — conventional laboratory sequencing rather than any single rapid technology.^[9][10] This pattern — genuinely faster triage for straightforward cases, with the hardest cases still requiring the full conventional toolkit — is a more accurate summary of 2023–2025 progress in disaster victim identification than any claim of a single transformative breakthrough.

12. Complex Mixtures and the Rise of Computational Interpretation

Pulling together Sections 3, 4, and 7: the throughline of 2023–2025 mixture interpretation is that improvement is coming from better statistical and computational methods layered onto existing detection technology, not primarily from more sensitive DNA detection. Inter-laboratory comparison studies exposed how much implementation choices inside probabilistic genotyping software still affect reported likelihood ratios; microhaplotype research showed sequence-based markers can outperform STRs for minor-contributor detection precisely because they avoid stutter artefacts; and the TPPR literature demonstrated that even a perfectly resolved mixture profile leaves the "how did it get there" question open. Sensitivity has plateaued relative to the problem that remains: turning a correctly detected mixture into a scientifically and legally defensible statement.

13. Proteomics, Microbiomes, and Molecular Autopsy

What Changed

Forensic proteomics — identifying individuals or determining cause of death from protein rather than DNA evidence — produced its most concrete 2023–2025 milestone not in a journal but in a government innovation award: in 2025, Western Australia's ChemCentre and PathWest laboratory won the WA Government Innovator of the Year award for developing a technique to identify individuals from the unique protein variants preserved in a single human hair shaft as short as one centimetre, offering an identification pathway when DNA has degraded beyond usability.^[31] On the molecular-autopsy side, review literature through 2023–2025 consistently framed proteomic, transcriptomic, and metabolomic "multi-omics" biomarkers as a promising complement to conventional autopsy and post-mortem genetic testing for sudden cardiac death cases that remain unexplained after standard investigation — work that explicitly still describes itself as research aiming toward, not yet delivering, routine diagnostic reliability.^[32][33]

Current Status

Hair-shaft protein identification is emerging, moving toward limited operational use in the specific jurisdiction (Western Australia) that developed it; it is not yet a validated, widely deployed method. Multi-omics molecular autopsy for sudden death remains firmly research-stage: a valuable complement to, not a replacement for, conventional forensic pathology. Microbiome-based forensic applications (post-mortem interval estimation, geolocation from microbial signatures) continued as active research areas in this period but did not surface any developmental-validation-stage studies suitable for casework citation, and this article accordingly declines to overstate their readiness.

14. What Did NOT Change

Hype resistance requires stating this plainly. Despite everything above:

• STR profiling remains the foundation of forensic DNA databases and the overwhelming majority of casework worldwide.
• Conventional capillary-electrophoresis DNA typing remains valid, admissible, and — for most casework — sufficient.
• Validation, quality assurance, and laboratory accreditation remain non-negotiable prerequisites for any new method reaching a courtroom.
• A DNA match does not establish guilt. It establishes, at most, a statistically weighted association with a biological source.
• DNA presence does not establish activity — a distinction the profession spent much of 2023–2025 explicitly reinforcing rather than eroding.^[6]
• Statistical interpretation — likelihood ratios evaluated under competing propositions — remains necessary; no method eliminates the need to interpret evidence rather than simply report it.
• DNA databases, population-genetic reference data, and contamination-control protocols remain as critical as ever, and in fact more so as marker systems multiply.
• Scientific uncertainty is unavoidable in every method discussed here, old or new.

15. Bayesian Interpretation and the Hierarchy of Propositions

Underlying nearly every development above is a single reasoning framework: forensic scientists evaluate the strength of evidence under two or more competing propositions, rather than calculating a "probability of guilt." This is formalised as a hierarchy of propositions, moving from source-level questions ("is this person a contributor to this stain?") through activity-level questions ("did this person deposit this stain during the alleged activity?") to offence-level questions ("did this person commit the offence?") — the last of which is a matter for the court, not the scientist, to decide.

Fig. 1 — The hierarchy of propositions in forensic DNA interpretation. 2023–2025 research concentrated heavily on the activity level, the tier where the profession's evidence base is weakest and where SWGDAM urged particular caution in formal reporting.

Match / No Match → Probabilistic Interpretation

Source → Activity

DNA Profile → Biological Information

Detection → Interpretation

16. Human Identification and Disaster Forensics

Kinship analysis, missing-persons identification, and disaster victim identification remain among forensic genetics' most consequential humanitarian applications, and the methods reviewed above are converging on them from several directions at once: MPS improves recovery from degraded remains; microhaplotypes improve kinship-analysis resolution for distant relatives; methylation-based age estimation narrows candidate pools when no reference sample exists; and Rapid DNA accelerates triage in the earliest, most chaotic hours of a disaster response. The Lahaina wildfire response is the clearest 2023–2025 case study demonstrating both the real gains and the enduring limits of this convergence.^[9]

17. The Indian Forensic Landscape: What Does the DNA Revolution Mean for India?

India's forensic DNA infrastructure sits at an inflection point that is more about capacity and legal mandate than about frontier science. Three developments define this period.

The Legal Mandate Expanded Sharply

The Bharatiya Nagarik Suraksha Sanhita (BNSS), 2023, which replaced the Code of Criminal Procedure with effect from 1 July 2024, mandates forensic investigation — including videographed search, seizure, and sample collection — for offences punishable by seven years' imprisonment or more.^[34] The Bharatiya Sakshya Adhiniyam (BSA), 2023, which replaced the Indian Evidence Act, gives explicit evidentiary status to electronic and forensic evidence, including DNA.^[34] Neither statute specifically legislates for activity-level interpretation, probabilistic genotyping thresholds, phenotyping, or investigative genetic genealogy — each of those remains governed, in practice, by laboratory protocol rather than statute.

Infrastructure Investment Followed

In June 2024, the Union Cabinet approved the National Forensic Infrastructure Enhancement Scheme (NFIES), a central-sector scheme under the Ministry of Home Affairs with a financial outlay of ₹2,254.43 crore for the period 2024–25 to 2028–29. The scheme funds nine additional campuses of the National Forensic Sciences University (NFSU), seven new Central Forensic Science Laboratories (CFSLs), and upgrades to NFSU's existing Delhi campus, with the explicitly stated purpose of addressing the surge in forensic caseload the BNSS mandate was expected to create, alongside a chronic shortage of trained forensic manpower and case backlogs in existing FSLs.^[35]

What This Does and Does Not Mean

NFIES is an infrastructure and workforce scheme, not a technology-adoption scheme. It says nothing officially documented about India acquiring probabilistic genotyping software at scale, deploying microhaplotype panels, building a validated Indian population-genetic reference database for ancestry-related markers, or adopting activity-level interpretation protocols. NFSU faculty and researchers have contributed to global forensic genetics scholarship, and Indian laboratories have long performed conventional STR-based DNA profiling competently within existing CFSL and state FSL networks — but no evidence located for this article documents routine Indian laboratory use of MPS-based sequencing, microhaplotypes, DNA phenotyping, or forensic epigenetics as of 2025.

Research/technology potential does not equal routine operational deployment in Indian forensic laboratories. The gap between what forensic genetics can now do globally and what is validated, funded, and routinely used in Indian FSLs remains substantial, and NFIES addresses capacity and manpower more directly than it addresses this technology gap.

Where India Is Positioned to Benefit

Disaster victim identification is the clearest near-term application, given India's exposure to mass-casualty events — the 2023 Odisha (Balasore) train collision and the 2024 Kanchanjunga Express accident both required DNA-based victim identification at scale using existing conventional methods. As NFIES-funded CFSL capacity comes online, the infrastructure to eventually adopt MPS-based approaches for exactly this kind of degraded-sample, high-volume identification work will exist — but adoption timelines, validation studies for Indian population data, and dedicated funding for these specific technologies remain, on current public evidence, undetermined.

18. The More DNA Can Tell Us, the Bigger the Ethical Question Becomes

Every capability gain catalogued above widens what a biological trace can reveal about a person — appearance, approximate age, distant relatives, activities, tissue of origin — and each widening raises a matching governance question. Investigative genetic genealogy depends on genealogical databases whose members mostly never anticipated forensic use of their data, and 2023–2025 research specifically quantified how often solving a case depends on testing people who never consented to forensic use at all.^[27] DNA phenotyping predicts traits correlated with ancestry, raising the risk that an investigative lead becomes a basis for discriminatory scrutiny of entire population groups, which is precisely the "technolegal mismatch" the 2023 CRIMTYP conference in Luxembourg was convened to examine.^[24] Activity-level and methylation-based methods generate inferences about a person's behaviour and biology from evidence they left unknowingly. None of these technologies is inherently good or dangerous; each is a capability whose value depends entirely on the governance, consent frameworks, and courtroom safeguards built around it — safeguards that, as the IGG bibliometric literature notes, currently lag well behind the pace of technical development, particularly for populations underrepresented in the reference databases these methods depend on.^[29]

19. The Legal and Evidentiary Dimension

None of the developments above automatically translate into courtroom admissibility in any given jurisdiction. In India, the Bharatiya Sakshya Adhiniyam, 2023 gives DNA evidence a recognised evidentiary footing, but the weight any specific method carries in a given case remains a matter for expert testimony, judicial evaluation, and precedent to establish — this article makes no claim about the admissibility of probabilistic genotyping, activity-level evaluation, or any emerging marker system in Indian courts, because no reliable evidence was located establishing settled Indian case law on these specific questions.^[34] In the United States, SWGDAM's 2025 caution against formal activity-level reporting is itself best read as an evidentiary-reliability judgment, anticipating exactly the kind of admissibility challenges that under-validated methods invite.^[6]

What Will Become Routine — and What May Not?

Based on the maturity classifications throughout this article, probabilistic genotyping for mixture interpretation and MPS-based sequencing for degraded and difficult samples are the developments most likely to become routine forensic practice globally within the next several years — both already have standards, validation frameworks, and increasing laboratory adoption behind them. Microhaplotypes and methylation-based age estimation are plausible candidates for the next wave of routine adoption once population reference databases mature. Formal activity-level reporting, broad-trait DNA phenotyping, and molecular autopsy multi-omics panels face a genuinely uncertain path — not because the underlying science is weak, but because validation, standardisation, and professional consensus on responsible use have not yet caught up with what is technically possible.

The Future of Forensic Genetics

If the 2019–2022 INTERPOL review captured a field consolidating probabilistic genotyping and beginning to explore sequencing, the 2023–2025 review captures a field turning its attention to the harder, messier questions that sit just past identity: how did this DNA get here, what does it reveal about the person who left it, and how far can any of that responsibly be stated in court.^[36] The trajectory suggests the next triennium will be less about new marker systems and more about closing the gap between what the science can technically do and what governance, validation, and courts are prepared to accept.

Timeline: How the Field Moved, Year by Year

2023

• Louisiana's Rapid DNA booking-station system goes fully operational following its 2022 authorization, generating early CODIS/DISC hits.^[17]
• August: the Lahaina, Maui wildfire tests Rapid DNA and conventional DVI methods together in a live mass-casualty response.^[10]
• September: the CRIMTYP conference in Luxembourg convenes forensic geneticists, lawyers, and ethicists specifically to scrutinise DNA phenotyping governance.^[24]
• India's Parliament enacts the BNSS and BSA, laying the statutory groundwork for expanded forensic mandates from mid-2024.^[34]

2024

• ISFG DNA Commission publishes formal STR sequence nomenclature recommendations, a key MPS standardisation step.^[21]
• Multiple inter-laboratory comparison studies on probabilistic genotyping reliability are published, alongside an updated UK Forensic Science Regulator guidance document.^[4][5]
• BNSS takes effect (1 July); Union Cabinet approves the ₹2,254.43-crore NFIES scheme (June) to meet the resulting forensic caseload.^[35]
• Peer-reviewed studies formally examine the privacy trade-offs of IGG reference testing and propose supportable-hypothesis frameworks for genealogy casework.^[27][28]

2025

• A comprehensive review on DNA transfer, persistence, prevalence, and recovery from human body areas is published, alongside multi-laboratory ReAct project data.^[13][14]
• FBI updates national Quality Assurance Standards (July) to permit evidence-sample Rapid DNA processing, though no cartridges are yet approved.^[18]
• ChemCentre/PathWest, Western Australia, wins a government innovation award for hair-shaft protein-based human identification.^[31]
• December: SWGDAM formally concludes that formal activity-level reporting is not yet suitable for U.S. forensic laboratory use.^[6]

The Revolution Scorecard

Maturity classifications below reflect the evidence reviewed in this article as of late 2025, using the categories defined earlier: Established, Emerging, Validation stage, Research stage, or Limited operational use.

Technology	What changed, 2023–2025	Scientific maturity	Current forensic value	Main limitation
Probabilistic genotyping	Inter-laboratory reliability testing; MPS-compatible validation	Established	High — standard for complex mixtures	Inter-lab LR variability persists
Activity-level interpretation	Major TPPR data expansion; formal caution from SWGDAM	Emerging / contested	High where validated (Netherlands, UK)	Insufficient standardised US data per SWGDAM
Rapid DNA (booking)	National rollout to booking stations; DISC search capability	Limited operational	High for arrestee identification	Not usable for casework mixtures
Rapid DNA (evidence)	QAS updated to permit it (2025)	Validation stage	Potential — DVI triage	No approved evidence cartridges yet
MPS / NGS	Nomenclature standardisation; PGS-for-sequence validation	Limited operational	High for degraded/complex samples	Cost, training, database incompatibility
Microhaplotypes	Multi-year NIJ panel-optimisation project; new validated panels	Validation stage	Promising for mixtures & ancestry	Needs population-specific databases
DNA phenotyping	Ethical/legal scrutiny intensified more than technical capability	Limited operational	Investigative leads only	Probabilistic, ancestry-correlated risk
DNA methylation / epigenetics	Nanopore single-assay age + fluid ID demonstrated	Validation stage	Useful for unidentified-persons cases	Accuracy drops at low read depth
Investigative genetic genealogy	Case volume growth; privacy-tradeoff quantified	Limited operational	High for cold cases, unidentified remains	Database coverage & consent gaps
Proteomics (hair-shaft ID)	WA government award for validated pilot capability	Emerging	Alternative when DNA is absent	Single-jurisdiction, early-stage
Molecular autopsy / multi-omics	Multi-omics reviews consolidate SCD biomarker research	Research stage	Complements autopsy-negative SCD cases	No single validated diagnostic biomarker

Myth vs. Fact

Myth: DNA always identifies the person who committed the crime.

Fact: DNA evidence can indicate the likely biological source of material found at a scene, but whether and how that connects to the offence itself depends on activity-level and offence-level reasoning the DNA result alone cannot supply.

Myth: New sequencing technology makes traditional STR profiling obsolete.

Fact: MPS expands what forensic genetics can read, but national DNA databases remain built on STR length data, and STR profiling remains the backbone of routine casework worldwide.

Myth: DNA phenotyping creates an exact picture of a suspect's face.

Fact: Validated phenotyping tools predict categorical traits — eye colour, hair colour, skin colour — with quantified probabilities. No forensic method reconstructs a face from DNA.

Myth: A likelihood ratio tells the court the probability that the defendant is guilty.

Fact: A likelihood ratio measures how much more likely the evidence is under one proposition than a competing one. Guilt is a legal determination the scientist does not make.

Myth: If a laboratory's probabilistic genotyping software is validated, its output is unquestionable.

Fact: 2023–2025 inter-laboratory studies found that different validated implementations of probabilistic genotyping can still produce different likelihood ratios for the same evidence, depending on parameter choices.

Myth: Investigative genetic genealogy only uses the DNA of the actual suspect.

Fact: IGG routinely involves testing distant relatives who never consented to forensic use of their genetic data, a trade-off that 2023–2025 research has begun to formally quantify.

Myth: Rapid DNA can now fully replace laboratory-based crime-scene DNA analysis.

Fact: As of the close of 2025, Rapid DNA remained largely confined to booking-station arrestee identification; no evidence-sample cartridges had been formally approved for casework use.

Conclusion: The DNA Revolution Is No Longer Just About Matching

The evidence assembled here does not support the idea that forensic genetics was reinvented between 2023 and 2025. What it supports is a more precise and, in the end, more interesting claim: the field spent this period converting a series of previously experimental capabilities — statistical mixture interpretation, activity-level reasoning, sequence-based typing, epigenetic and proteomic biomarkers, genealogical database searching — into methods with real validation data, real limitations documented in the open literature, and in at least one prominent case (activity-level reporting), a formal professional judgment that the science, however promising, is not yet ready for standardised use.

The fundamental transformation is not that DNA now tells investigators more. It is that forensic genetics is becoming more explicit, in public and peer-reviewed literature, about exactly how much any given piece of DNA evidence can responsibly be asked to say. The old question was "whose DNA is this?" The question this period leaves the field asking is harder and more honest: what biological information can this evidence actually provide, how strongly does it support one explanation over its competitors, and what can be responsibly inferred from it — no more, and no less?

---

References

1. Butler, J.M. (2026). INTERPOL Review of Forensic Biology and DNA, 2023–2025. Forensic Science International: Synergy, 13, Article 100705. doi.org/10.1016/j.fsisyn.2026.100705
2. U.S. Department of Justice (2019). Interim Policy on Forensic Genetic Genealogical DNA Analysis and Searching.
3. Chaitanya, L. et al. HIrisPlex-S System for Eye, Hair and Skin Colour Prediction from DNA: Introduction and Forensic Developmental Validation. Forensic Science International: Genetics.
4. Boodoosingh, S., Kelly, H., Curran, J.M., Kalafut, T. (2024). An inter-laboratory comparison of probabilistic genotyping parameters and evaluation of performance on DNA mixtures from different laboratories. Forensic Science International: Genetics, Article 103046.
5. UK Forensic Science Regulator (2024, updated 22 July). Software Validation for DNA Mixture Interpretation (FSR-G-223), Issue 2.
6. Scientific Working Group on DNA Analysis Methods (SWGDAM) (2025). Position Statement on Formal Activity Level Reporting (ALR). Approved by Executive Board 3 November 2025 and Membership 1–2 December 2025.
7. Davoren, J.M., Bode Technology (2023–2025). Optimization of Microhaplotypes for Advanced DNA Mixture Deconvolution. National Institute of Justice-funded study, ICPSR 39750.
8. Huang, Y., Qu, S., Xiao, Y., Jian, H., Liang, W. (2023). Progress in age estimation based on DNA methylation. Journal of Forensic Science and Medicine, 9(4), 360–366.
9. Massachusetts Institute of Technology Technology Review (16 May 2024). This grim but revolutionary DNA technology is changing how we respond to mass disasters.
10. Associated Press (17 August 2023). Identifying victims of the Maui wildfire will be a challenging task. Here's what it entails.
11. McNevin, D., Barash, M. (2024). Comparison of Likelihood Ratios from Probabilistic Genotyping for Two-Person Mixtures across Different Assays and Instruments. Forensic Sciences, 4(3), 441–452.
12. Developmental validation of STRmix NGS, a probabilistic genotyping system for sequence data. Forensic Science International: Genetics, 62, Article 102804 (early online Nov 2022; published Jan 2023).
13. Woollacott, C., Goray, M., van Oorschot, R.A.H., Taylor, D. (2025). The Transfer, Prevalence, Persistence, and Recovery of DNA from Body Areas in Forensic Science: A Review. Forensic Sciences, 5(1), 9.
14. ReAct project (28 January 2025). Analysis of data from 23 different laboratories to characterise DNA recovery given two sets of activity level propositions.
15. Roebuck Forensics / Forensic Science International: Genetics (2024). Study on DNA-TPPR in home environment scenarios relevant to activity-level evaluations.
16. Roebuck Forensics / Forensic Science International: Genetics (2024). Survey of court-attending forensic biology scientists on the prevalence of activity-level questioning.
17. Hares, D. / ISHI (2023). Rapid DNA Authorization to Operate timeline: Louisiana (April 2022), Florida (December 2022), FBI (May 2023).
18. Texas Department of Public Safety (2025). Rapid DNA Analysis FAQ, citing July 2025 FBI Quality Assurance Standards update permitting evidence-sample Rapid DNA processing.
19. FBI Law Enforcement (2025). Guide to All Things Rapid DNA (03/1/2025 edition).
20. Alaska Department of Public Safety, Division of Victim Assistance and Forensic Science (2 September 2025). Rapid DNA Technology Overview and Implementation Memo.
21. Ballard, D., Parson, W., Benschop, C.C.G., Børsting, C., Budowle, B., Butler, J.M., Vennemann, M., Phillips, C. (2024). Recommendations of the DNA Commission of the ISFG on short tandem repeat sequence nomenclature. Forensic Science International: Genetics, 68, Article 102946.
22. Martin, D. (2025). Investigation into implementing a massively parallel sequencing workflow for forensic human identification in South Africa. University of Cape Town.
23. Gu, C., Huo, W., Huang, X. et al. (2024). Developmental and validation of a novel small and high-efficient panel of microhaplotypes for forensic genetics by next generation sequencing. BMC Genomics, 25(1), Article 10880.
24. University of Luxembourg, CRIMTYP Project (21–22 September 2023). Forensic DNA Phenotyping: The Ethics of Forensic Genetics, Effective Social and Legal Oversight, and Technical Advancements [conference programme].
25. Beentjes, I., Haagmans, M.A., de Bruin, D.D.S.H., Permana, A. et al. (2026). DNA methylation-based forensic framework for age prediction and body fluid identification using nanopore sequencing. Forensic Science International: Genetics, 81, Article 103370.
26. Dowdeswell, T. (2024/2025). Forensic Genetic Genealogy Project dataset. Mendeley Data.
27. Hu, Y., Wein, L.M. (2024). Analysis of the privacy-performance tradeoff of reference testing in Forensic Investigative Genetic Genealogy. Journal of Forensic Sciences, 69(5), 1699.
28. Budowle, B., Baker, L., Sajantila, A., Mittelman, K., Mittelman, D. (2024). Prioritizing privacy and presentation of supportable hypothesis testing in forensic genetic genealogy investigations. Biotechniques.
29. A bibliometric analysis of investigative genetic genealogy in academic literature: Trends, networks, and emerging themes (2026). Forensic Science International: Synergy, 12, Article 100663.
30. FBI / Bureau of Justice Assistance National Sexual Assault Kit Initiative (11 April 2024). Forensic Genetic Genealogy Refresher Course agenda.
31. ChemCentre, Government of Western Australia (2025). Forensic Proteomics: human hair-shaft protein-based identification — WA Government Innovator of the Year Award.
32. Cătinaș, R.M., Hostiuc, S. (2025). The Latest Advances in Omics Technology for Assessing Tissue Damage: Implications for the Study of Sudden Cardiac Death. International Journal of Molecular Sciences, 26(14), 6818.
33. Sacco, M.A., Gualtieri, S., Calanna, L., Ricci, P., Aquila, I. (2023). Exploring the Potential of Proteome Analysis as a Promising Tool for Evaluation of Sudden Cardiac Death in Forensic Settings: A Literature Review. International Journal of Molecular Sciences, 24(18), 14351.
34. Government of India. Bharatiya Nagarik Suraksha Sanhita, 2023 (effective 1 July 2024); Bharatiya Sakshya Adhiniyam, 2023.
35. Ministry of Home Affairs, Government of India (2024). National Forensic Infrastructure Enhancement Scheme (NFIES) — official scheme page.
36. Butler, J.M. (2023). Recent advances in forensic biology and forensic DNA typing: INTERPOL review 2019–2022. Forensic Science International: Synergy, 6, Article 100311.